BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-17035 | Pharmaceuticals and Medical
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Biological anthrax (anthrax vaccine) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET
7.1 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA BIOLOGICAL ANTHRAX (ANTHRAX VACCINE) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 IVPM
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Ceva Santé Animale
16.3 Prondil
16.4 Indian Immunologicals
16.5 CVCRI
16.6 JOVAC
16.7 PharmAthene
16.8 Vecol
16.9 Bayer Sanidad Animal
16.10 CDV
16.11 Zoetis
16.12 Merial
16.13 Merck
16.14 Biogénesis-Bago
16.15 Colorado Serum
16.16 Intervac
16.17 Rosenbusch
16.18 Agrovet
16.19 Botswana Vaccine Institute
16.20 CAVAC
16.21 Tiankang
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredCell free PA vaccine
Live vaccine
Major Downstream Industry Covered
Animal use
Human use
Companies
IVPM
Ceva Santé Animale
Prondil
Indian Immunologicals
CVCRI
JOVAC
PharmAthene
Vecol
Bayer Sanidad Animal
CDV
Zoetis
Merial
Merck
Biogénesis-Bago
Colorado Serum
Intervac
Rosenbusch
Agrovet
Botswana Vaccine Institute
CAVAC
Tiankang
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.